Wednesday, 11 May 2011 10:05
The adoption of Bacopa monniera (brahmi) by SFI with the American Botanical Council’s Adopt-An-Herb program will ensure up-to-date clinical information for Bacopa monniera is easily available via HerbMedProTM.
HerbMedProTM is an electronic herbal database that provides hyperlinked access to the scientific data underlying the use of herbs for health. It is an evidence-based information resource for healthcare professionals, researchers, and the general public.
SFI’s responsibility as adopter of Bacopa monniera is to keep information for all research on this valuable herb for cognitive health up-to-date. This will include SFI’s KeenMindTM (CDRI 08), with its specific Bacopa monniera formulation and seed-to-patient quality control. KeenMind® is supported by clinical evidence demonstrating its efficacy as a cognitive enhancer with consistent results for memory, concentration and mental clarity. SFI’s dedication to KeenMindTM and Bacopa monniera is also demonstrated by its commitment to additional clinical development to further examine its cognitive benefits.
SFI’s specifically clinically proven Bacopa monniera product KeenMind®